Market & Regulation
BillionToOne Goes Public as Biotech Innovator
Y Combinator Bloghigh confidence
Why it matters
- →This development highlights the intersection of biotech and AI, showcasing how machine learning can enhance genetic testing.
BillionToOne has gone public, becoming Y Combinator's fourth biotech company. Their prenatal genetic test is now used for 1 in 11 babies born in the U.S.
Read original
